SEER, INC.
Medtech · Private
Blood-based diagnostic test for Alzheimer's disease using the Proteograph platform—a nanotechnology-enabled proteomics system that profiles plasma protein signatures via nanoparticle protein corona te
- Grants
- $2.0M
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 12 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Rapid Profiling of the Plasma Proteome and Machine Learning Analytics for Non-Invasive Diagnosis of Alzheimer's Disease | $1,130,758 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid Profiling of the Plasma Proteome and Machine Learning Analytics for Non-Invasive Diagnosis of Alzheimer's Disease | $910,258 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1924 | IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC | — | — |
| 1925 | BIOSYNTAGMA, LLC | — | — |
| 1926 | WEARABLE DEFENSE LLC | — | — |
| 1927 | SEER, INC. | — | — |
| 1928 | ADDINEX TECHNOLOGIES, INC. | — | $1.5M |
| 1929 | ViaLase, Inc. | — | $76M |
| 1930 | R3 Vascular Inc. | — | $75M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptide Decorated Nanoparticles For Enrichment Of Specific Protein Subsetsapplication
- Methods And Apparatuses For Detecting Biomolecule And Analyte Interactionsapplication
- Systems And Methods For Sample Preparation, Data Generation, And Protein Corona Analysisgranted
- Methods And Systems For Glycoprotein Assaysapplication
- Systems And Methods For Discovery And Analysis Of Markersgranted
- Functionalized Macromolecules And Systems, Methods Of Synthesis, And Uses Thereofapplication
- Compositions, Methods And Systems For Protein Corona Analysis And Uses Thereofapplication
- Methods For Analyzing Biological Samplesapplication
- Methods For Using A Machine Learning Algorithm For Omic Analysisapplication
- Systems And Methods For Biomolecule Assaysapplication
- Compositions, Methods And Systems For Protein Corona Analysis And Uses Thereofgranted
- Methods For Detecting Metabolic Markersapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.